![Cintia Piccina](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cintia Piccina
Corporate Officer/Principal at
AUTOLUS THERAPEUTICS PLC
Net worth: 3 999 $ as of 30/06/2026
Profile
Cintia Piccina is currently Chief Commercial Officer at Autolus Therapeutics Plc since 2025.
Former roles include Chief Commercial Officer at Adaptimmune Therapeutics Plc from 2022 to 2023, Chief Commercial Officer at AlloVir, Inc. from 2023 to 2024, SVP-Commercial Oncology & US General Manager at 2seventy Bio, Inc. from 2021 to 2022, and Vice President-Oncology at Novartis Pharmaceuticals Corp.
from 1997 to 2020.
Education includes a doctorate from the University of Sao Paulo and an MBA from Escola Superior de Propaganda e Marketing.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 11/04/2025 | 6,66,438 ( 0.04% ) | 3 999 $ | 30/06/2026 |
Cintia Piccina active positions
| Companies | Position | Start |
|---|---|---|
| AUTOLUS THERAPEUTICS PLC | Corporate Officer/Principal | 01/09/2025 |
Former positions of Cintia Piccina
| Companies | Position | End |
|---|---|---|
| ALLOVIRPAR | Corporate Officer/Principal | 01/03/2024 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | 05/03/2023 |
| 2SEVENTY BIO, INC. | Corporate Officer/Principal | 01/02/2022 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/04/2020 |
| ADAPTIMMUNE THERAPEUTICS PLC | Corporate Officer/Principal | - |
Training of Cintia Piccina
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
93
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
University of Sao Paulo
 University of Sao Paulo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Escola Superior de Propaganda e Marketing
 Escola Superior de Propaganda e Marketing Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
AlloVir, Inc.
 AlloVir, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies for severe infections | Health Technology |
Autolus Therapeutics Plc
 Autolus Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the development and commercialization of gene therapies | Health Technology |
2seventy Bio, Inc.
 2seventy Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals for the treatment of cancer and genetic diseases | Health Technology |
- Stock Market
- Insiders
- Cintia Piccina
